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A decrease in the lineage commitment of multipotent Mesenchymal stem cells (MSC) to the bone forming osteoblast
lineage and an increase in the commitment to the fat forming adipocyte lineage is more common in bone marrow of
elderly persons. A link between methylation status and MSC differentiation remains unclear. Therefore, we hypothesize
that hypomethylation may decide the fate decisions of MSC. In the current study, murine bone marrow derived-C3H10T1/
2 stem cell was used to examine the role of methylation mechanism on the differentiation potential of stem cells into
osteoblasts or adipocytes. C3H10T1/2 cells were treated with Periodate oxidized adenosine (Adox), an inhibitor of
S-adenosylhomocysteine-dependent hydrolase (SAHH), which in turn block the non-DNA methylation pathway. The effect
of hypomethylation on C3H10T1/2 stem cell differentiation was determined by measuring the alkaline phosphates activity
and the degree of mineralization as well as Oil-red O staining and lipid content. The ratio of S-adenosylmethionine (SAM)
and S-adenosylhomocysteine (SAH) was determined as a metabolic indicator of cellular methylation potential. It was
clearly observed that hypomethylation significantly (P < 0.05) reduces SAM: SAH ratio, alkaline phosphates activity,
calcification and thereby, osteoblast differentiation. Conversely, adipocyte differentiation was stimulated by
hypomethylation. Altogether, our data suggest that non-DNA hypomethylation changes the differentiation potential of
C3H10T1/2 stem cells for less osteogenic and more adipogenic.
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MSC are multipotent adult stem cells of mesodermal
origin with the capacity to differentiate into cells of vari-
ous multiple tissues, e.g., muscle, bone, cartilage, fat, and
marrow stroma (Otto and Rao 2004). Multipotent MSC
can be isolated from various adult tissues such as bone
marrow (Conget and Minguell 1999), skeletal muscle
(Asakura et al. 2001), adipose tissue (Zuk et al., 2002)
umbilical cord blood (Romanov et al. 2003) and fetal
lung (Anker et al. 2003). MSC can easily be harvested from
bone marrow. When placed in culture, bone marrow-
derived MSC retain their multipotential capacity and can* Correspondence: sshrmany@yahoo.co.uk
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in any medium, provided the original work is pdifferentiate into at least osteoblasts, chondrocytes and ad-
ipocytes (Pittenger et al., 1999). Methionine is converted
to S-adenosylmethionine (SAM) by the enzyme methio-
nine adenosyltransferase (MAT) during methylation path-
way. SAM is the major biological methyl group donor to
a large variety of acceptor substrates, including DNA,
RNA, phospholipids, and proteins. S-adenosylhomocysteine
(SAH) is formed, through donation of a methyl group,
which is subsequently hydrolyzed to homocysteine by the
enzyme SAH hydrolase (SAHH) (Hoffman et al., 1980;
Chiang et al., 1996).
The ratio SAM/SAH is an important metabolic marker
for cellular methylation status and also known methyla-
tion potential (MP) (Marina et al., 2004). Previous stud-
ies in vitro have been reported that inhibition of SAHH
enzyme results in decreased SAM levels as a result of
decreased methyltransferase activity leading to reduced
SAM/SAH ratio in presence of significant increase inpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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thermore, an altered SAM/SAH ratio by inhibition of
SAH hydrolase results in inhibition of DNA, RNA, and
protein and lipid methylation (Caudill et al. 2001). Thus,
considering the crucial role of methylation in various
cellular processes, it is known that any alteration in the
availability of SAM may have profound impacts on cellular
growth, differentiation, and function (Carmel and Jacobsen
2001). Previous studies as demonstrated in vitro and in vivo
have provided evidence that chronic elevation in plasma
Hcy associated with vitamins deficiencies have an indirect
and negative effect on cellular SAH levels, which should
result in feedback inhibition of SAM-dependent methyl-
transferase reactions and reduced methylation capacity.
This has to lead to the following hypothesis that homocyst-
eine is a metabolic marker for a reduced methylation activ-
ity (Afman et al., 2005; Chen et al., 2001; Ping et al. 2000).
The proper differentiation potential of Mesenchymal stem
cell (MSC) into osteoblasts or adipocytes determines the
balance between osteoblast and adipocyte number and
activity, which is required to maintain bone and fat homeo-
stasis. Therefore, disturbance of this equilibrium may con-
tribute to the pathology of metabolic diseases such as
ageing and osteoporosis (Elena et al., 2004; Toru et al.,
2004). Research in recent years has been demonstrated that
treatment of embryonic stem cells with retinoic acid in-
duces a MSC-like intermediate cell that can subsequently
be differentiated into osteoblasts, chondrocytes or adipo-
cytes, but the underlying mechanisms remain to be solved.
Moreover, the exact nature of progenitor cells that are
responsible for the lineage commitment of mesenchy-
mal stem cells is less well understood than in the case
of hematopoietic stem cells due to a lack of specific
markers to characterize intermediate stages. MSC and
primary cultures need to be isolated freshly, thereby intro-
ducing possible variations between experiments as a result
of cell isolations from different donors (Dani et al., 1997;
Kawaguchi et al. 2005).
Clonal cell lines have the advantage that they provide
homogenous populations that can often be maintained
in culture for many passages. In order to study mecha-
nisms of lineage specification, it is necessary to use cells
with the flexibility to differentiate into multiple mesen-
chymal lineages. Examples of cell lines with this property
are the adult mouse bone marrow-derived fibroblastic
cell line C3H10T1/2 (10 T1/2) which has been derived
from early mouse embryos. C3H10T1/2 stem cells can
be stimulated by various external factors to differentiate
into the three cell types osteoblasts, chondroblasts, and
adipocytes (Otsuka et al. 1999; Ding et al. 2003).
The mechanisms that determine whether MSC dif-
ferentiate into osteoblasts or adipocytes are still poorly
understood. Recently, (Milhem et al., 2004) reported that
DNA methylation plays an important role in the regulationof hematopoietic stem cell switching, but the link between
methylation pathway and MSC differentiation remain am-
biguous. Therefore, in this study it is hypothesized that the
alterations in the commitment and differentiation potential
of MSC during ageing may be explained by modification of
non- DNA methylation pathway. Finally, to assess the role
of demethylation potential in modifying stem cells fate de-
cisions, SAH hydrolase in C3H10T1/2 stem cells was inhib-
ited with peroidate oxidized adenosine (Adox) in vitro. The
capacity of this agent to modulate osteoblast differentiation
was analyzed under non-osteogenic control conditions and
during growth factor-induced differentiation.
Materials and methods
Materials
Culture media (DMEM & αMEM), fetal bovine serum
(FBS), L-glutamine, penicillin/streptomycin, and phos-
phate buffered saline (PBS) were obtained from (Lonza).
Insulin from Novo Nordisk was used. The mouse em-
bryo C3H10T1/2 fibroblasts cells were purchased from
American Type Culture Collection (ATCC). The remaining
tissue culture materials, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT), dimethyl sulfoxide
(DMSO) and periodate-oxidized adenosine (adenosine-2,
3-dialdehyde) (Adox) were obtained from Sigma Chemical
Company Netherlands.
Cell culture
In this study, C3H101/2 stem cells (10 T1/2)-derived
from C3H mouse embryos were used. C3H101/2 stem
cells are functionally similar to MSCs and have the poten-
tial to differentiate into multiple cell types, for example,
osteoblasts, adipocytes or chondrocytes dependent on the
stimulation agents that have been used. The cell culture
took place in a humidified atmosphere containing 5% CO2
at 37°C. After reaching a confluency of 70-80%, all cells
were rinsed with PBS (Lonza), treated with trypsin-EDTA
(0.25 mg/dl) (Cambrex) until cells detached, and subse-
quently passed at lower density to new flasks in culture
medium. Control medium consists of Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% FBS,
2 mM L-glutamine, and 1% penicillin (100 U/ml) / strepto-
mycin (100 μg/ml). The cells were cultured in presence
or absence of series concentrations of Adox. Osteoblast
differentiation (OB) medium consists of control medium
supplemented with 12, 5 mM β-glycerophosphate, 50 μg/
ml ascorbic acid and 1 mM dexamethasone. Adipocyte dif-
ferentiation (AD) medium consists of control medium sup-
plemented with 1 mM dexamethasone, 5 μg/ mL insulin,
111 μg/ml 3-isobutyl-methyl xanthine (IBMX) and 1 μM
rosiglitazone was added as well. All cell lines in culture
medium were seeded in DMEM/10% FBS at a density of
1.0 x 104 cells/cm2. Differentiation was initiated two days
later (t0) by removing the culture medium and replacing
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medium or adipocyte differentiation medium as supplied
by the manufacturer. From t0, cells were exposed to series
concentrations of Adox.
Cell viability by MTT assay
Cell death or cytotoxicity is classically evaluated by the
quantification of plasma membrane damage. The cyto-
toxicity of Adox on seeded C3H10T1/2 stem cells was
colorimetrically evaluated by measuring the formation of
formazin salts because of the reduction of 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
reagents. The increase in the amount of formazan pro-
duced in culture supernatant directly correlates to the
increase in the number of lysed cells. The formazan dye
is water-soluble and can be detected by spectrophotom-
eter at 570 nm. The MTT-cytotoxicity assay is sensitive,
convenient, and precise, and is applicable to a variety of
cytotoxicity studies.
The cells were cultured for 24 hrs. Then, Adox in dif-
ferent concentrations (10-100 μM) were added. After 24
and 72 hours incubation, 20 μl of 5 mg/ml MTT reagents
were added to each well. Then, the wells were incubated
for 4 h at 37°C and the formazen crystals were dissolved
by adding 200 μl of dimethyl sulfoxide (DMSO) at 37°C
for 30 min. The optical density of the wells was read at
570 nm on a microplate reader (Molecular Devices Inc.,
Sunnyvale, CA, USA). The rate of cell death was specified
relative to control group.
Determination of SAM and SAH levels
Measurement of SAM and SAH concentration in culture
medium was done according to the method of (Dani
et al. 1997). The SAM and SAH was briefly extracted from
cultured cell, and then 80 μl of o.1 M sodium acetate buf-
fer, pH 6.0, was added to a soft pellet containing a known
number of cells. After the cells were lysed with the sodium
acetate, 20 μl of 40% TCA were added. The solution was
vortex-mixed and allowed to stand on ice for 30 min. The
solution was centrifuged at 25,000 g for 10 min at 5°C,
and 100 μl of the supernatant were transferred to another
0.5 ml eppendorf tube. The solution was extracted twice
with an equal volume of diethyl ether, and was filtered
through a 0.2- μm filter. Then, the solution was injected
into the high-performance liquid chromatography (HPLC)
system. Detection of SAM and SAH was performed using
a CoulArray electrochemical detector (ESA, Chelmsford,
MA). Peak area analysis was carried out by HPLC based
on calibration curves generated for each compound.
Alkaline phosphate assay
To measure the progress of osteoblast differentiation in
C3H10T1/2 cultured cells, the activity of the protein Al-
kaline Phosphatase (ALP) assay was measured. Briefly,cells were cultured in 96-wells plates and medium con-
ditions were applied in triplicate. A spectrophotometic
analysis of ALP protein activity was performed at various
time points. The cells were rinsed with cold PBS, and
fixed with 4% paraformaldehyde for 10 minutes at 4°C.
Subsequently, a dilution of P-nitrophenyl phosphate
(pNPP) (Sigma) was used based on the type of cell line.
Substrate for ALP was added and the plate was incu-
bated at 37°C for 30 minutes. The color reaction, taking
place through the conversion of pNPP to p-nitrophenol by
ALP, was stopped by addition of NaOH and the extinction
was measured at 405 nm with a MultiSkan Ascent spec-
trophotometer (Thermo Labsystems) and version 2.4.2
MultiSkan Ascent software.
Neutral red assay
To correct for cell numbers during the ALP assay, a
Neutral Red (NR) assay was carried out. This assay is
always performed in combination with ALP assay that
so-called ALP/NR assay to correct the cell numbers by
dividing the result of the ALP assay by the result of the
NR assay. Based on manufacture’s protocol, cells were
seeded in 96-wells plates and medium conditions were
applied in triplicate. Neutral Red (Sigma) (1 mg/ml) was
diluted in PBS, then added to each well of a 96-wells
plate and the plates were incubated at 37°C for one hour.
Subsequently the cells were rinsed with PBS and the
remaining absorbed NR was released by adding an elution
solution. Extinction measurements were performed at
550 nm on a MultiSkan spectrophotometer.
Alkaline phosphatase / Oil-red-O staining
To visualize the amount of osteoblasts and adipocytes,
alkaline phosphatase / Oil-red-O staining (ALP/ORO) was
used. Briefly, Oil-red-O staining was performed on distinct
time points. The cells were fixed for 30–60 seconds with
citrate-buffered acetone (kit from Sigma-Aldrich) and then
washed twice with MilliQ water (MQ). ALP staining was
performed by adding a dye mixture of diazonium salt solu-
tion and Naphtol AS-MX phosphate alkaline solution
(Sigma-Aldrich). The cells were incubated in the dark for
30 minutes to 3 hours at 37°C until the blue staining was
visible. After which they were rinsed with MQ water. For
subsequent lipid droplets staining, an Oil-Red-O (Sigma)
working solution was added and the plate was incubated
for 15 minutes at 37°C. The cells were rinsed once again
with MQ and photographs were taken under the micro-
scope (Olympus CKX41) using an Olympus C-5050 Zoom
camera and Olympus DP-soft version 3.2 software.
Quantification of mineralization
This assay is performed to measure the amount of cal-
cium deposited, which is formed during the later stage
of osteoblast differentiation as an indicator for the level
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24-wells plates and medium conditions were applied.
Calcium deposition was measured with a calcium release
assay when the whole time-series was isolated. The cells
were incubated with HCL (0.5 M) and shaken overnight.
A color reaction was performed by adding 25 μl of the
collected and centrifuged HCL samples to a mix of o-
cresolphthalein complexone, 8-quinolinol and 2- amino-
2-methyl-1, 3-propanediol (Sigma) in cuvettes. A blank
(25 μl HCL) and a standard series of calcium solution,
were included. Extinction was determined at 575 nm on
a UV mini 1240 spectrophotometer (Shimadzu).
Quantification of lipid
A triglyceride assay was performed to measure the de-
gree of adipocyte differentiation and lipid accumulation.
Since, adipocytes are a highly specialized cell type in-
cluded in the store and accumulate lipid as triglyceride
in response to adipogenic factors such as insulin, dexa-
methasone, rosiglitazone and IBMX. Briefly, cells were
seeded in 24-wells plates and medium conditions were
applied in duplicate followed by rinsing with PBS, then
incubated with a Tris–HCl EDTA solution at −20 until
all samples were collected.
Plates were brought to room temperature to determine
triglyceride content according to the protocol. A stand-
ard series was included by adding triglyceride standard
(kit from iNstrucchemie, ref # 10720P) to wells without
cells. 40 μl Tertiary butanol and 10 μl methanol were
added to the wells to extract the triglycerides from the
cells, and shaking for 10 minutes. A color reaction was
performed by adding the reagent triglycerides Liquico-
lour Mono (kit from iNstruchemie, ref #10720P). After
shaking for 20 minutes, samples were pipetted into a 96-
wells plate and extinction was measured at 492 nm with
a MultiSkan spectrophotometer.
Statistical analysis
Data are expressed as the mean ± standard deviation.
One way-ANOVA (SPSS version 20.0) and LSD post hoc
test were used to determine the mean differences between
groups. Values are considered significantly different at the
level of < 0.05.
Results
Cell cytotoxicity
Incubation with 10–100 μM Adox for 24 and 72 hrs, did
not show any cell cytotoxicity when compared with
(DMSO) as a solvent control (the final concentration of
DMSO was 0.2%) as shown in Figure 1.
SAH and SAM levels
To investigate whether intracellular SAH and SAM are in-
volved in the non-DNA hypomethylation, we measuredintracellular SAH and SAM during incubation with vari-
ous concentrations of Adox (10-50 μM). As shown in
(Table 1), incubation with DMEM and OB medium (as a
negative control) did not change intracellular SAH and
SAM levels in C3H10T1/2 stem cells. However, incuba-
tion of cells with 10–50 μM Adox significantly enhanced
increased intracellular SAH levels (3.99 ± 0.19 nmol/L)
compared with (1.6 ± 0.48 nmol/L) in controls. SAM/SAH
ratio was also determined in cells incubated for 48 h with
Adox (Table 1). Incubation of C3H10T1/2 stem cells with
50 μM Adox decreased the SAM/SAH ratio in culture
medium (18.2 ± 0.26 to 8.5 ± 0.18, p < 0.05).
Osteoblast differentiation
Continuous treatment the confluent cells with differenti-
ation inducers resulted in terminal osteoblast differenti-
ation. Adox was used as a potent methylation inhibitor
because it has been shown to inhibit methylation path-
way in previous studies (Afman et al., 2003 & Afman
et al. 2005).
ALP staining
Cells were stained with alkaline-dye to visualize the
amount of differentiated osteoblasts from MSCs. Cells
were cultured in control medium without any supple-
ments and OB medium supplemented with (ascorbic
acid, beta-glycerophosphae, vitamin D and dexametha-
sone) in the presence of series concentrations of Adox
(5 - 50 μΜ) and then stained for ALP-positive cells using
ALP staining on day 11, the resulting pictures are pre-
sented in Figure 2.
The blue staining indicates osteoblast differentiation.
The pictures show that in OB medium large numbers of
the human stem cells were differentiated into osteoblasts
that express high amount of ALP compared with those
in control medium due to the potent effect of osteogenic
supplements that were used for osteoblast differenti-
ation. A marked decrease in the number of ALP-positive
cells treated with series concentrations of Adox compared
with the number of positive cells in untreated osteogenic
medium (OB) can be observed. This result indicates that
osteogenesis is decreased due to the inhibition of methyla-
tion pathway in C3H10T1/2 stem cells.
Alkaline phosphatase activity
To quantify the result of osteoblast differentiation in
cells, ALP assay was done. Cells were treated with differ-
ent concentrations of Adox (5–50 μM). The influence of
Adox on the synthesis of ALP by osteoblasts was deter-
mined by measuring ALP activity, corrected for cell number
as determined by neutral red adsorption. ALP activity was
measured on day 8 and day 11 respectively, and the result-
ing graph is shown in Figure 3. As observed by spectro-





















Figure 1 Effect of Adox on cell cytotoxicity in C3H10T1/2 stem cells. Cells were treated with different concentrations of Adox for 24 and
72 hrs. Cells in control were cultured in OB medium treated with (DMSO) as a solvent control (the final concentration of DMSO was 0.2%). The
other cells were cultured in OB medium containing different concentrations of Adox (10-100 μM). Cell cytotoxicity was determined by MTT assay
and expressed as a percentage of viable cells in the total number of cells counted. Values are means ± SD (n = 3) for each treatment.
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A marked decrease in the ALP activity compared with
the ALP activity in osteogenic medium can be observed
in the cells that have been treated with series concentra-
tions of Adox.Mineralization
To investigate the effect of inhibition of the methylation
pathway by Adox on matrix calcification or mineralization,
a calcium release assay was performed in cells. Cells were
grown in control and osteogenic medium for 20 days and
the calcium release assay was measured on t14, t17, and
t20. From the results shown in Figure 4, it can be stated
clearly that osteogenic agents have stimulatory effect on
calcium release in osteogenic medium compared with con-
trol medium. While, Adox in treated cultures has strongTable 1 Effects various concentrations of Adox on
content of SAM, SAH and SAM: SAH ratios for 48 h in
C3H10T1/2 stem cells1
Treatment SAH2 (nmol/L) SAM (nmol/L) SAM: SAH ratio
Control 1.6 ± 0.48a 28 ± 0.41b 17.5 ± 0.28c
DSMO + OB 1.7 ± 0.38a 31 ± 0.32b 18.2 ± 0.26c
Adox + OB
10 μM 1.9 ± 0.12a 35 ± 0.25c 18.4 ± 0.16ba
25 μM 2.66 ± 0.14b 33 ± 0.29a,b 12.4 ± 0.14c
50 μM 3.99 ± 0.19c 34 ± 0.23b 8.5 ± 0.18b,c
1Cells in the control condition were only exposed to control medium without
any osteogenic supplements, the other cells were cultured in OB medium
treated with (DMSO) as a solvent control (the final concentration of DMSO was
0.2%). Cells in OB (osteogenic medium) exposed to OB medium without Adox
treatment. The other cells were cultured in OB medium containing different
concentrations of Adox (5-50 μM). 2Values are means ± SD of triplicate assays.
Data in the column with different superscript letters are significantly
different (P < 0.05).an inhibitory effect on calcium release at every time points
compared with osteogenic medium. A dramatic repression
is achieved on exposure to 50 μM of Adox, which disables
the cells to calcify at all.
Adipocyte differentiation
The confluent cells were cultured in control medium
lacking adipogenic agents and in adipogenic medium
containing differentiation inducers dexamethasone, insu-
lin, rosiglitazone and isobutylmethylxanthine. Cells treated
with different concentrations of Adox (5-50 μΜ) and then
stained for lipid droplets using an ORO staining on day 9,
the resulting pictures are presented in Figure 5.
ORO staining
The red spots indicate accumulation of lipid droplets, serv-
ing as an indication of adipocyte differentiation. The pic-
tures clearly show that in adipogenic medium, C3H12T1/2
cells were differentiated into adipocytes that produce lipid
droplets compared with those in control medium due to
the potent effect of adipogenic supplements that were used
for adipogenic differentiation. However, higher numbers of
C3H10T1/2 stem cells were differentiated into adipocytes
in the cells that have been treated with series concentration
of Adox compared with Ad medium lacking Adox treat-
ment. Interestingly, the treated cells with a higher con-
centration of Adox have been filled with an extensive
accumulation of lipid droplets compared with adipocytes
in Ad medium.
Lipid quantification
To quantify the result of adipocyte differentiation of
C3H10T1/2 stem cells, a triglyceride assay was carried
out. The result is shown in Figure 6, and a great similar-
ity with ORO staining can be observed especially at t4
and t6. At every time point a positive effect of adipogenic
µMControl                                           OB                                  10
25µM                                           50µM
Figure 2 Photographs of C3H10T1/2 stem cells treated with Adox on day 11. All cells were stained with alkaline-dye, according to the
protocol described in material and methods. All cells in the control were only exposed to control medium without any osteogenic supplements.
Cells in OB (osteogenic medium) exposed to OB medium without Adox treatment. The other cells were cultured in OB medium containing different
concentrations of Adox (10-50 μM).
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with control medium. Whereas, Adox treatment clearly
results in induction of the amount of triglycerides in a
dose dependent way in treated cells compared with those
in adipogenic medium.
Osteoblast and adipocyte differentiation
We next studied the effect of Adox on osteogenesis and
adipogenesis simultaneously to assess the role of methyla-
tion pathway on the osteoblast and adipocyte differenti-
ation together. The C3H10T1/2 stem cells were used and
stained with alkaline-dye mixture and ORO staining. The
result is shown in Figure 7 respectively. The blue staining
indicates osteoblast differentiation, whilst the red spots



















Figure 3 ALP/NR assays of C3H10T1/2 stem cells treated with Adox. T
protocol in materials and methods. Cells in the control condition were onl
Cells in OB (osteogenic medium) exposed to OB medium without Adox treat
concentrations of Adox (5-50 μM). Results are expressed as means ± SD (n = 3differentiation. Although the medium was meant to
trigger osteogenesis, the adipocyte formation was grown
in OB medium.
Discussion
In the present study we have investigated the role of hypo-
methylation in commitment and cellular differentiation of
multipotent C3H10T1/2 stem cells as characterized by
SAM/SAH ratio, ALP/NR, calcium release, triglyceride as-
says and ALP/ORO staining. Our results clearly showed
that that murine C3H10T1/2 cells have many features of
mesenchymal stem cells. Also, it was demonstrated that
non-DNA hypomethylation reduces stem cells differenti-
ation into mature osteoblasts and therefore, inhibits osteo-
genesis in stem cells; this indicates that hypomethylation**
5 10 25 50




he assays were performed on t8 and t11 respectively, according to the
y exposed to control medium without any osteogenic supplements.
ment. The other cells were cultured in OB medium containing different































Figure 4 Calcium release assay of C3H10T1/2 treated with Adox. The assays were performed on day 14, day 17 and day 20 respectively,
according to the protocol in materials and methods. Cells in the control condition were only exposed to control medium without any osteogenic
supplements, the other cells were cultured in OB medium. Cells in OB (osteogenic medium) exposed to OB medium without Adox treatment.
The other cells were cultured in OB medium containing different concentrations of Adox (5-50 μM). Results are expressed as means ± SD (n = 3).
*P < 0.05, **P < 0.01 in comparison with control group values.
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Moreover, this study demonstrated that the inhibitory ef-
fect of hypomethylation is not restricted on the early stage
of stem cells but also this effect persists throughout the
later stage of osteoblast differentiation as has been shown
in the level of calcification that already committed to osteo-
blast lineage Figure 4. The results obtained from calcium
release in C3H10T1/2 stem cells were very interesting and
showed that hypomethylation also inhibits mineralization
of matrix proteins that is the major function of osteoblast.
On the other hand, demethylation obviously enhances stem
cells differentiation into mature adipocytes and therefore,
induces adipogenesis in C3H10T1/2 cells. This result is in
line with other study performed in embryonic stem cells re-
ported that DNA hypomethylation associated with lipidControl Ad
5µM 25µM
Figure 5 Photographs of C3H10T1/2 stem cells treated with Adox on
described in material and methods. All cells in the control were only expos
Ad medium without Adox treatment. The other cells were cultured in Ad mdeposition in the proximal portion of the aorta of mice
in vivo (Chen et al., 2001). But, C3H10T1/2 cells don not
show any stimulatory or inhibitory effect under the influ-
ence of demethylation in the presence of rosiglitazone.
However, another study showed that blocking DNA methy-
lation by using another methylation inhibitor called Aza
in C3H10T1/2 stem cells without roziglitazone, resulted
in stimulation of adipogenesis after culturing for 28 days
(Taylor and Jones, 1979). One of the explanations is that
adipocte differentiation was very strong due to the strong
effect of rosiglitazone a potent inducer of adipocyte differ-
entiation. That means if Adox would stimulate adipocyte
formation it cannot be detected. Furthermore, the influ-
ence of demethylation on osteogenesis and adipogenesis
were studied simultaneously Figure 7. It was observed that1µM
50µM
day 14. All cells were stained with Oil-red-O, according the protocol
ed to control medium. Cells in Ad (Adipogenic medium) exposed to































Figure 6 Triglyceride of C3H10T1/2 stem cells treated with Adox on day 4 and day 6 respectively. All measurements were done as
duplicate and averaged, according to the protocol described in material and methods. All cells in the control were only exposed to control
medium. Cells in Ad (Adipogenic medium) exposed to Ad medium without Adox treatment. The other cells were cultured in Ad medium
containing different concentrations of Adox (5-50 μM). *P < 0.05, **P < 0.01, ***P < 0.01 in comparison with control group values.
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osteogenesis and an increase of adipogenesis. These find-
ings clearly show the role of methylation pathway as a key
regulator of stem cell differentiation switch into less osteo-
genic and more adipogenic cells. Since, demethylated stem
cells failed to differentiate into osteoblasts but differenti-
ated into adipocytes in OB medium of stem cells, which
has been used to trigger osteogenesis. The high degree of
adipogenesis in Figure 7 was unexpected. The inverse rela-
tion between the number of osteoblasts and the number
of adipocytes under the effect of demethylation reveals the
importance of the methylation pathway in MSC for proper
commitment and differentiation. In addition, the role of
methylation pathway as a key regulator for stem cell dif-
ferentiation is also observed in hematopoietic stem cell
(HSC) (Milhem et al., 2004). after being treated with AzaControl OB 
10 µM. 25
Figure 7 Photographs of C3H10T1/2 stem cells treated with Adox on
according to the protocol described in material and methods. All cells in the
medium. Cells in OB (osteogenic medium) exposed to OB medium without A
different concentrations of Adox (5-50 μM). The other cells were cultured in Oa potent DNA methylation inhibitor and TSA as histone
deacetylation inhibitor resulting in a significant alteration
in the fate of HSC (Boer et al. 2006). The ratio of SAM to
SAH (the substrate or product) of most cellular methyl-
transferase reactions is generally considered to be predict-
ive of cellular methylation mehanism. Several studies have
confirmed the decrease in SAM as the major effector of
the reduced ratio and of methylation mechanism (Lathrop
Stern et al. 2000; Loehrer et al., 1996; Simile et al., 1994).
The primary importance of SAH as a mediator of
methylation status was recently reported in a human study
in which it was found that increased levels of plasma
homocysteine and intracellular SAH, without concurrent
changes in SAM, were associated with lymphocyte DNA
hypomethylation (Yi et al., 2000). In the present study,
Adox methylation inhibitor was used to modulate SAM                                 5µM
µM 50µM
day 11. All cells were stained with alkaline-dye mixture and Oil-red-O,
control were only exposed to control medium without any osteogenic
dox treatment. The other cells were cultured in OB medium containing
B medium containing different concentrations of Adox.
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to determine which intracellular metabolite has a greater
effect on non- DNA methylation and determine whether
stem cells differentiate into osteoblasts or adipocytes. The
relationship among SAM, SAH and non-DNA hypome-
thylation observed in the culture medium confirmed the
importance of SAH as the primary determinant of re-
duced methylation capacity (see Table 1).
These findings support the concepts that methylation
modification may play an important role in the differen-
tiation switching of stem cells. In this study it must be
mentioned that the present results of osteoblast differen-
tiation by our model systems are not in agreement with
previous studies that showed that DNA demethylation
by Aza agent in C3H10T1/2 cells and MG63 cells is asso-
ciated with elevation of ALP expression and mineralization
and therefore, osteoblast differentiation (Boer et al., 2006;
Rachel et al., 1998). A possible explanation for the lowered
osteoblast differentiation in our study after treated the cells
with Adox could be resulted from demethylation of pro-
tein, lipid or RNA but DNA methylation might not be in-
volved in the negative effect of demethylation. Since, that
DNA methylation is not influenced by short-term alter-
ations in methylation potential as has been observed previ-
ously by (Marina et al. 2004), who reported that a reduced
methylation potential in HepG2 cells by Adox does not
change the global DNA methylation while, mRNA methy-
lation is reduced within 24 h. Moreover, others showed a
clear reduction in protein methylation after Adox treat-
ment (Delong et al., 2002; Li et al., 1998). However, in our
study we do not examine global DNA methylation but
based on the literatures we propose that DNA methylation
could be not changed via inhibition of methyl acceptors
that are involved in the process of cellular differentiation
of MSC. Since, Adox was used to block methylation of
lipid and protein but not DNA or RNA, indirectly by in-
hibition of SAH hydrolase enzyme in methylation cycle,
therefore, it is not known exactly which methyl acceptor is
inhibited and caused reduction for osteoblast differenti-
ation. But, Aza in the previous studies has been directly
incorporated into DNA molecule and thereby prevent
methylation of DNA in the replicated stem cells.
Although these data support the possibility that alter-
ation in the balance between osteoblast and adipocyte dif-
ferentiation during osteoporosis and ageing might be
mediated by hypomethylation. Further studies are needed
to clarify the influence of an altered of methylation path-
way on DNA, mRNA or protein methylation separately to
elucidate whether the effect is due to a changed methyla-
tion of DNA, mRNA or due to the modification of protein
methylation. Furthermore, determination of DNA hypo-
methylation levels and epigenetic regulation of stem cells
is highly recommended as robust parameter for cellular
methylation status.Conclusion
In summary, the results of this study demonstrate that
hypomethylation changes the differentiation potential of
C3H10T1/2 stem cells for more adipogenic and less osteo-
genic. Our results also show that epigenetic regulation of
mesenchymal stem cell could open new strategy for thera-
peutic intervention of osteopenic disorders. However, fur-
ther studies are still needed to investigate the influence of
global DNA hypomthylation on the differentiation poten-
tial of mesenchymal stem cell markers in vitro and vivo.
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